Objective. Hepcidin, a recently discovered antimicrobial peptide synthesized in the liver, was identified to be the key mediator of iron metabolism and distribution.
Introduction
Hepcidin is small cystein-rich peptide produced mainly in the liver. First described as a 25-amino acid (aa) antimicrobial peptide (hepatic bactericidal protein) (Park et al. 2001) , it was subsequently found to be a powerful negative regulator of iron absorption. Hepcidin is a key regulator of iron metabolism playing an important role in the pathogenesis of anemia of chronic disease (Ganz 2006) . It has a crucial role in the pathogenesis of hemochromatosis and related disorders (Papanikolaou et al. 2005 ).
Human hepcidin is produced from a 54-aa precursor including a putative 24-aa signal peptide. The early studies showed that hypoxia, iron, and inflammation influence hepcidin levels, but the exact mechanism remained elusive (Nicolas et al. 2002 , Krijt et al. 2009 ). The synthesis is up-regulated in intact animals by the injection of lipopolysaccharide (endotoxin) and interleukin (IL)-6 although a direct stimulating effect of other cytokines as IL-1α, and IL-1β was confirmed in in vitro studies (Lee et al. 2005) . Due to dominant regulation by IL-6, hepcidin was classified as a type II acute-phase protein (Nemeth et al. 2003) .
Despite our knowledge of hepcidin regulation and activities increased considerably in recent years, there are only limited data on hepcidin in human subjects, and much of findings come from animal and in vitro models. While quantitative methods have been used for the determination of serum prohepcidin, the technical problems prevented reliable and routine measurements of active 25-aa hepcidin in plasma until 2009.
Authors of the present study used a specific group of cardiosurgical patients undergoing pulmonary endarterectomy (PEA) in a deep hypothermic circulatory arrest (DHCA). PEA represents as a model of cytokine network hyperstimulation and intensive time-limited non-infectious inflammatory reaction. Our previous studies (Maruna et al. 2008 , Maruna et al. 2009 ) as well as other authors (Langer et al. 2004 , Martínes-Rosaz 2006 reported that PEA -as a large cardiac surgery -leads to a more pronounced activation of cytokines than other surgical procedures. This cytokine 'burst' mediates a systemic response by the body's inflammatory system, well known as the systemic inflammatory response syndrome. PEA is a potential curative treatment method for patients with chronic thromboembolic pulmonary hypertension (CTEPH). PEA provides a significant survival advantage, compared to the natural prognosis of CTEPH (Roscoe and Klein 2008) . At the other side the postoperative course after PEA is accompanied by a number of specific complications, which need the prolonged care in Intensive Care Units and also contribute to the high rate of early postoperative mortality, which ranges from 5 to 23%. The kinetics of main pro-4 inflammatory cytokines after PEA were described by Lindner et al. (2009) showing the relations of cytokine network to hemodynamic disturbances post-surgery.
In a prospective study, the time course of plasma hepcidin was analyzed in relations to six inflammatory parameters -plasma cytokines and acute-phase proteins in patients undergoing uncomplicated PEA in DHCA. Respecting gender differences in hepcidin basal concentrations with significantly higher levels in men (Grebenchtchikov et al. 2009 ), only male patients were included into our study.
Authors hypothesized that post-surgery changes of plasma hepcidin concentrations would be responding to dynamics of other acute-phase proteins and related to interleukin-6 or other main inflammatory cytokines development.
Material and methods
A prospective study was approved by local research and ethics committee and a written informed consent was obtained from the subjects. Monitoring. Radial and femoral artery cannulae, triple lumen central venous cannula, Swan-Ganz catheter, and single lumen jugular bulb catheter were inserted for continuous monitoring of hemodynamic parameters and jugular bulb blood saturation.
Left atrial catheter was surgically placed for both measurement and norepinephrine administration.
Blood sample collection. Arterial blood samples were drawn from femoral artery catheter before operation, after sternotomy, after DHCA, after separation from CPB, then 12, 18, 24, 36, 48, 72 , and 120 h after separation from CPB. For all measurements, 5-ml of arterial blood was drawn into a vacutainer heparin tube and immediately centrifuged at 5000 rpm for 15 min. Plasma was stored at -80°C until analysis.
Hepcidin, cytokines and acute-phase proteins analysis. Plasma hepcidin concentration
was measured by enzyme-linked immunoassay using a commercially available kit (DRG Diagnostics, Marburg, Germany) in duplicates -the analytical sensitivity of the assay was 0.9 ng/ml, intra-assay coefficients of variation (CV) calculated by DRG Diagnostics was below 5%, inter-assay precision was 11% (6,0 ng/ml) and 10% ( were measured in duplicates, too. The intra-and inter-assay CV were below 5%.
Hemodynamic parameters. Mean pulmonary artery pressure (MPAP), cardiac index (CI), pulmonary vascular resistance (PVR), and ejection fraction (EF) were followed.
The time of norepinephrine support was recorded in all patients.
Plasma iron (colorimetric analysis, Pliva-Lachema a.s., Brno, Czech Republic), ferritin, and transferrin (immunoturbidimetry, Dialab Gmbh, Wr. Neudorf, Austria)
were examined preoperatively and repeatedly within 120 h after the end of surgery.
Statistical analysis was carried out using SPSS software (version 12.0) for Windows (SPSS, Chicago, USA). The normal distribution of all data was examined using the An uncomplicated course after PEA was associated with a transient initial decline of hepcidin and subsequent elevation (Fig. 1) . Minimal hepcidin concentrations were found in blood samples collected after the last DHCA. Initial decline of hepcidin appeared to correlate with the decreased hematocrit due to hemodilution on CPB (r = 0.84, p = 0.003). During perioperative period, hepcidin increased from preoperative level 8.9 ng/ml (6.2 -10.7) (median and interquartile range) to maximum 16.4 ng/ml (14.1 -18.7) measured 72 h after the end of surgery (e.g., separation from CPB). After it, the levels started declining but were still higher than pre-operatively until 120 h after the end of surgery.
IL-6, IL-8, and TNFα initial decline with minimum levels after the last DHCA was related to hemodilution and cleared after correction to hematocrit. IL-6 and TNFα culminated 12 h after separation from CPB (Table 3) Individual maximum doses of norepinephrine during PEA were compared with cytokine, hepcidin and other acute-phase protein levels in the same period, however without statistical significance for any of the inflammatory parameters.
Discussion
In the study, authors report a significant alteration of plasma hepcidin in patients undergoing a large cardiac surgery. Hepcidin concentrations increased postoperatively reaching a maximum 72 h after the separation from CPB. In a homogenous group of uncomplicated surgical patients, significant correlation between hepcidin and IL-6 concentrations post-surgery was observed.
Nine years after discovery of hepcidin, our work is the first clinical study evaluating early post-operative changes of plasma hepcidin on a larger group of patients. Several Variables are absolute number or mean (standard deviation). Variables are means (standard deviation). Postoperative data are given 24 hours after admission to intensive care unit.
Abbreviations: DHCA = Deep hypothermic circulatory arrest, CPB = Cardiopulmonary bypass. 
